세계의 POCT(Point-of-Care 검사) 심장질환 시장 : 기회와 전략(-2033년)
POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033
상품코드:1596075
리서치사:The Business Research Company
발행일:2024년 11월
페이지 정보:영문 284 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 현장진단(POCT) 심장질환 시장은 2018년 13억 3,259만 달러로 평가되었으며, 2023년까지 6.00% 이상의 연평균 성장률(CAGR)을 나타낼 것으로 예상됩니다.
휴대용 및 웨어러블 기기의 채택 증가
휴대용 및 웨어러블 기기의 채택이 증가하면서 POCT(Point-of-Care Testing) 심장질환 시장 성장에 기여한 것으로 나타났습니다. 휴대용 심전도(ECG) 모니터와 웨어러블 심박수 모니터를 포함한 휴대용 및 웨어러블 POCT 기기는 환자와 의료 서비스 제공업체가 기존의 병원 환경을 넘어 심장 검사를 수행할 수 있게 했습니다. 이러한 편의성 향상으로 더 자주 검사를 받고 심장 질환을 조기에 발견할 수 있게 되어 시장 성장을 가속하고 있습니다. 예를 들어, 미국에 본사를 둔 크리에이티브 디지털 에이전시인 Digital Silk에 따르면, 세계 웨어러블 기술 시장은 빠르게 발전하고 있으며, 2022년까지 전 세계 웨어러블 기기 수가 11억 대를 넘어설 것으로 예상하고 있습니다. 주목할 만한 점은 웨어러블 기술을 도입한 기업의 79%가 웨어러블 기기가 기업의 성공에 필수적인 역할을 하고 있다고 답했으며, 76%는 전반적인 성과 향상을 경험했다고 답했습니다. 또한, 이들 기업의 86%는 웨어러블에 대한 투자를 늘릴 계획이며, 이는 다양한 산업에서 비즈니스 성과를 개선하고 혁신을 촉진하는 기술의 능력에 대한 강한 믿음을 반영합니다. 따라서 휴대용 및 웨어러블 기기의 채택이 증가함에 따라 POCT(Point-of-Care Testing) 심장 질환 시장의 성장을 주도하고 있습니다.
목차
제1장 주요 요약
POCT(Point-of-Care 검사) 심장질환 시장의 매력과 거시경제 상황
제2장 목차
제3장 표 리스트
제4장 그래프 리스트
제5장 보고서 구성
제6장 시장 특징
일반적인 시장의 정의
개요
POCT(Point-of-Care 검사) 심장질환 시장 정의와 세분화
시장 세분화 : 유형별
디지털 앱(헬스케어 솔루션)
소형 검체 검사기기
시장 세분화 : 최종사용자별
병원
진단 실험실
기타 최종사용자
제7장 주요 시장 동향
제8장 POCT(Point-of-Care 검사) 심장질환 시장 - 거시경제 시나리오
COVID-19의 영향 : POCT(Point-of-Care 검사) 심장질환 시장
우크라이나 전쟁의 영향 : POCT(Point-of-Care 검사) 심장질환 시장
고인플레이션의 영향 : POCT(Point-of-Care 검사) 심장질환 시장
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2018-2023
시장 성장 촉진요인, 2018-2023
시장 성장 억제요인, 2018-2023
시장 성장 예측, 2023-2028, 2033F
시장 성장 촉진요인, 2023-2028
시장 성장 억제요인, 2023-2028
세계의 POCT(Point-of-Care 검사) 심장질환 시장 : 유형별, 분석과 예측, 2018-2023, 2028F, 2033F
세계의 POCT(Point-of-Care 검사) 심장질환 시장 : 최종사용자별, 분석과 예측, 2018-2023, 2028F, 2033F
제10장 POCT(Point-of-Care 검사) 심장질환 시장 : 지역/국가별 분석
세계의 POCT(Point-of-Care 검사) 심장질환 시장 : 지역별, 분석과 예측, 2018-2023, 2028F, 2033F
세계의 POCT(Point-of-Care 검사) 심장질환 시장 : 국가별, 분석과 예측, 2018-2023, 2028F, 2033F
제11장 아시아태평양 시장
제12장 서유럽 시장
제13장 동유럽 시장
제14장 북미 시장
제15장 남미 시장
제16장 중동 시장
제17장 아프리카 시장
제18장 POCT(Point-of-Care 검사) 심장질환 경쟁 구도와 기업 개요
Wondfo Biotech Co. Ltd.
Siemens Healthineers AG
Business Strategy
QuidelOrtho Corporation
F. Hoffman-La Roche Ltd
Abbott Laboratories
OraSure Technologies Inc.
Hologic Inc.
Thermo Fisher Scientific Inc.
SARSTEDT AG & Co. KG
Nova Biomedical Corporation
제19장 디지털 앱(헬스케어 솔루션) 경쟁 구도와 기업 개요
디지털 앱(헬스케어 솔루션) 시장 기업 개요
QuidelOrtho Corporation
Withings SA
AliveCor Inc.
Business Strategy
Preventice Solutions Inc.(Boston Scientific)
Koninklijke Philips N.V.(Philips Cardiologs)
Qardio Inc.
HeartFlow Inc.
iRhythm Technologies Inc.
LumiraDx Ltd.
Huma Ltd.
제20장 소형 검체 검사기기의 경쟁 구도와 기업 개요
소형 검체 검사기기 시장 기업 개요
Wondfo Biotech Co. Ltd.
Company Overview
Products And Services
Financial Overview
Siemens Healthineers AG
F. Hoffman-La Roche Ltd
QuidelOrtho Corporation
OraSure Technologies Inc.
Hologic Inc.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Business Strategy
SARSTEDT AG & Co. KG
Nova Biomedical Corporation
제21장 주요 인수합병(M&A)
Roche Holding AG Acquired LumiraDx
SD Biosensor, Inc And SJL Partners Acquired Meridian Bioscience, Inc
Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
세계의 POCT(Point-of-Care 검사) 심장질환 시장, 2028 : 새로운 기회를 제공하는 국가
세계의 POCT(Point-of-Care 검사) 심장질환 시장, 2028 : 새로운 기회를 제공하는 부문
세계의 POCT(Point-of-Care 검사) 심장질환 시장, 2028 : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제23장 POCT(Point-of-Care 검사) 심장질환 시장 : 결론과 제안
결론
제안
제품
장소
가격
프로모션
사람
제24장 부록
LSH
영문 목차
영문목차
Point-of-care testing (POCT) for cardiac disease refers to diagnostic tests performed near or at the site of patient care, allowing for rapid results without the need for centralized laboratory testing. These tests are designed to detect and monitor various cardiac conditions, including acute coronary syndromes, heart failure and other cardiovascular disorders.
The POCT (point of care testing) cardiac disease market consists of sales, by entities (organizations, sole traders and partnerships), of POCT (point of care testing) cardiac disease systems, solutions and services that play a critical role in emergency and urgent care settings, where timely decision-making can significantly impact patient outcomes. The primary users of these tests include healthcare professionals such as doctors, nurses and paramedics, who utilize them to quickly assess cardiac biomarkers, such as troponins and natriuretic peptides, to aid in diagnosing heart attacks or monitoring heart function.
The global POCT (point of care testing) cardiac disease market was valued at $1,332.59 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.
Increasing Adoption Of Portable And Wearable Devices
Increasing adoption of portable and wearable devices contributed to the growth of the POCT (point of care testing) cardiac disease market in the historic period. Portable and wearable POCT devices, including handheld electrocardiogram (ECG) monitors and wearable heart rate monitors, enabled patients and healthcare providers to perform cardiac tests beyond traditional hospital environments. This increased convenience facilitated more frequent testing and earlier detection of cardiac issues, thereby driving market growth. For instance, according to Digital Silk, a US-based creative digital agency, the global wearable technology market is rapidly evolving. By 2022, the number of connected wearable devices worldwide was estimated to exceed 1.1 billion. Notably, 79% of companies that have adopted wearable technology reported that these devices play a vital role in their success, while 76% saw improvements in overall performance. Furthermore, 86% of these companies plan to increase their investment in wearables, reflecting a strong belief in the technology's ability to enhance business outcomes and drive innovation across various industries. Therefore, the increasing adoption of portable and wearable devices drove the growth of the POCT (point of care testing) cardiac disease market.
Launch Of New Point-Of-Care Tests For Heart Failure
Companies operating in POCT (point of care testing) cardiac disease are launching new point-of-care tests for heart failure which ensures that the test meets the needs of a substantial patient demographic and helps allocate resources effectively to those who need them most. For instance, in April 2024, F. Hoffmann-La Roche AG, a global healthcare leader based in Switzerland, introduced a new POC test for heart failure in India, specifically tailored for patients with diabetes. The NT-proBNP test is designed to support early screening for cardiovascular conditions, including heart failure, in individuals with type 2 diabetes. This test operates on the Cobas h 232 system, which enables rapid testing and delivers immediate results in clinical environments. This advancement is pivotal in identifying patients at risk of heart failure earlier, thereby allowing for timely intervention and improved patient care.
The global POCT (point of care testing) cardiac disease market is fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 6.37% of the total market in 2023.
POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global POCT (point of care testing) cardiac disease market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for POCT (point of care testing) cardiac disease? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The POCT (point of care testing) cardiac disease market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider POCT (point of care testing) cardiac disease market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the POCT (point of care testing) cardiac disease market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market..
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for POCT (point of care testing) cardiac disease providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type: Digital Apps (Healthcare Solutions); Small Specimen Devices
2) By End User: Hospitals; Diagnostic Laboratories; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; POCT (point of care testing) cardiac disease indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 POCT (Point of Care Testing) Cardiac Disease - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 POCT (Point of Care Testing) Cardiac Disease Market Definition And Segmentations
6.4 Market Segmentation By Type
6.4.1 Digital Apps (Healthcare Solutions)
6.4.2 Small Specimen Devices
6.5 Market Segmentation By End-User
6.5.1 Hospitals
6.5.2 Diagnostic Laboratories
6.5.3 Other End-Users
7 Major Market Trends
7.1 Increase In Approvals Of Point-Of-Care Test That Deliver Fast Cardiac Troponin Results
7.2 Launch Of New Point-Of-Care Tests For Heart Failure
7.3 Advanced Point-Of-Care Testing Devices Revolutionize Health Diagnostics
7.4 Merger And Acquisitions To Strengthen Market Position
8 POCT (Point of Care Testing) Cardiac Disease Market - Macro-Economic Scenario
8.1 COVID-19 Impact On The POCT (Point of Care Testing) Cardiac Disease Market
8.2 Impact Of The War In Ukraine On The POCT (Point of Care Testing) Cardiac Disease Market
8.3 Impact Of High Inflation On The POCT (Point of Care Testing) Cardiac Disease Market
9 Global Market Size And Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
9.4 Global POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
9.5 Global POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10 POCT (Point of Care Testing) Cardiac Disease Market, Regional and Country Analysis
10.1 Global POCT (Point of Care Testing) Cardiac Disease Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global POCT (Point of Care Testing) Cardiac Disease Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.1.1 Market Overview
11.1.2 Region Information
11.1.3 Market Information
11.1.4 Background Information
11.1.5 Government Initiatives
11.1.6 Regulations
11.1.7 Regulatory Bodies
11.1.8 Major Associations
11.1.9 Taxes Levied
11.1.10 Corporate Tax Structure
11.1.11 Investments
11.1.12 Major Companies
11.2 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.3 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.4 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
11.5 China Market
11.6 Summary
11.6.1 Market Overview
11.6.2 Country Information
11.6.3 Market Information
11.6.4 Background Information
11.6.5 Government Initiatives
11.6.6 Regulations
11.6.7 Regulatory Bodies
11.6.8 Major Associations
11.6.9 Taxes Levied
11.6.10 Corporate Tax Structure
11.6.11 Investments
11.6.12 Major Companies
11.7 China POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.8 China POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.9 India Market
11.10 India POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.11 India POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.12 Japan Market
11.13 Japan POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.14 Japan POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.15 Australia Market
11.16 Australia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.17 Australia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.18 Indonesia Market
11.19 Indonesia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.20 Indonesia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.21 South Korea Market
11.22 South Korea POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.23 South Korea POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market: Country Analysis
12.5 UK Market
12.6 UK POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.7 UK POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.8 Germany Market
12.9 Germany POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 Germany POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 France Market
12.12 France POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 France POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 Italy Market
12.15 Italy POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.16 Italy POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Spain Market
12.18 Spain POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Spain POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
13.5 Russia Market
13.6 Russia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.7 Russia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 North America Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 North America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 North America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 North America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
14.5 USA Market
14.6 Summary
14.6.1 Market Overview
14.6.2 Country Information
14.6.3 Market Information
14.6.4 Background Information
14.6.5 Government Initiatives
14.6.6 Regulations
14.6.7 Regulatory Bodies
14.6.8 Major Associations
14.6.9 Taxes Levied
14.6.10 Corporate Tax Structure
14.6.11 Investments
14.6.12 Major Companies
14.7 USA POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 USA POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Canada Market
14.10 Canada POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.11 Canada POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 South America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 South America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 South America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 South America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
15.5 Brazil Market
15.6 Brazil POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.7 Brazil POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 Middle East POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 Middle East POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Africa Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Africa POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Africa POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Egypt Market
17.5 Egypt POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.6 Egypt POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Competitive Landscape and Company Profiles
18.1 Wondfo Biotech Co. Ltd.
18.1.1 Company Overview
18.1.2 Products And Services
18.1.3 Financial Overview
18.2 Siemens Healthineers AG
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Business Strategy
18.2.4 Financial Overview
18.3 QuidelOrtho Corporation
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Financial Overview
18.4 F. Hoffman-La Roche Ltd
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Business Strategy
18.4.4 Financial Overview
18.5 Abbott Laboratories
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Financial Overview
18.6 OraSure Technologies Inc.
18.6.1 Company Overview
18.6.2 Products And Services
18.6.3 Financial Overview
18.7 Hologic Inc.
18.7.1 Company Overview
18.7.2 Products And Services
18.7.3 Financial Overview
18.8 Thermo Fisher Scientific Inc.
18.8.1 Company Overview
18.8.2 Products And Services
18.8.3 Business Strategy
18.8.4 Financial Overview
18.9 SARSTEDT AG & Co. KG
18.9.1 Company Overview
18.9.2 Products And Services
18.9.3 Financial Overview
18.10 Nova Biomedical Corporation
18.10.1 Company Overview
18.10.2 Products And Services
18.10.3 Financial Overview
19 Digital App (Healthcare Solution) Competitive Landscape and Company Profiles
19.1 Digital App (Healthcare Solution) Market Company Profiles
19.2 QuidelOrtho Corporation
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Financial Overview
19.3 Withings SA
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Financial Overview
19.4 AliveCor Inc.
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Preventice Solutions Inc. (Boston Scientific)
